DrugCard

Good people leaving increases the retention costs, while the new talent costs more. Heavy investments in staff training and onboarding new talents

DrugCard automates pharmacovigilance work for drug safety teams, using AI to screen medical literature and track regulatory intelligence. Its platform monitors global and local literature sources, including local medical journals, and the company contrasts its automated screening with manual screening. Additional modules cover PSUR and PBRER automation, an adverse event database, a simple search tool and eCTDlight.

Alongside the software, DrugCard offers services such as LQPPV, signal management, ICSR management, PSMF management, risk management plans, pharmacovigilance training and consultancy. The site also addresses implementation and onboarding, compliance and audit readiness, and publishes case studies and documents. Filed in the research category with health and research assistant tags, it is meant for pharmaceutical safety professionals rather than general users.

Pricing is not published; the site directs visitors to request a demo or contact the company. Request a demo to see how it screens the journals relevant to your products.

Category: Research. Pricing: enterprise. Visit website

Alternatives to DrugCard in Research

• Yila AI — Evidence-traceable research agent for literature review, PDF analysis, figures, and academic slides.
• Deep Search — AI web research, chat and public-information lookups
• ScholarIQ — ScholarIQ searches 470M+ articles from OpenAlex, ORCID and PubMed — and answers in plain language, with every claim cit…
• Tracetify — Evidence-led competitor launch intelligence for founders and marketers.
• XLeadForge — X outbound, queued daily in your voice
• Reverse Image Location — AI image geolocation and visual clue analysis